Cargando…

Exploration of Malignant Characteristics in Neoadjuvant Chemotherapy-Resistant Rectal Cancer, Focusing on Extramural Lesions

BACKGROUND: Extramural vascular invasion (EMVI) and tumor deposits (TD) are poor prognostic factors in rectal cancer (RC), especially when resistant to neoadjuvant chemotherapy (NAC). We aimed to define differential expression in NAC responders and non-responders with concomitant EMVI and TD. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kubota, Shunsuke, Miura, Takuya, Wakiya, Taiichi, Yoshizawa, Tadashi, Goto, Shintaro, Morohashi, Hajime, Sakamoto, Yoshiyuki, Tatara, Yota, Kijima, Hiroshi, Hakamada, Kenichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2023
Materias:	Colorectal Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10562322/ https://www.ncbi.nlm.nih.gov/pubmed/37548833 http://dx.doi.org/10.1245/s10434-023-13928-z

Ejemplares similares

Investigating the association between radiological images and the pathology of rectal cancer treated with neoadjuvant chemotherapy
por: Morohashi, Satoko, et al.
Publicado: (2019)

Heterogeneity of metabolic adaptive capacity affects the prognosis among pancreatic ductal adenocarcinomas
por: Kanda, Taishu, et al.
Publicado: (2022)

Three-dimensional analysis of perineural invasion in extrahepatic cholangiocarcinoma using tissue clearing
por: Ogasawara, Hirokazu, et al.
Publicado: (2023)

Eukaryotic initiation factor 2 signaling behind neural invasion linked with lymphatic and vascular invasion in pancreatic cancer
por: Wakiya, Taiichi, et al.
Publicado: (2021)

Effective dissection for rectal cancer with lateral lymph node metastasis based on prognostic factors and recurrence type
por: Morohashi, Hajime, et al.
Publicado: (2021)

Use of time‑density curves of dynamic contrast‑enhanced computed tomography for determination of the histological therapeutic effects of neoadjuvant chemotherapy for pancreatic ductal adenocarcinoma
por: Goto, Shintaro, et al.
Publicado: (2023)

Clinical Significance of Extramural Tumor Deposits in the Lateral Pelvic Lymph Node Area in Low Rectal Cancer: A Retrospective Study at Two Institutions
por: Yagi, Ryoma, et al.
Publicado: (2016)

A case report of mucinous adenocarcinoma derived from intra-ampullary papillary-tubular neoplasm with a malignant course
por: Fujita, Hiroaki, et al.
Publicado: (2021)

T‐stage downstaging of locally advanced rectal cancer after neoadjuvant chemoradiotherapy is not associated with reduced recurrence after adjusting for tumour characteristics
por: Hayes, Ian P., et al.
Publicado: (2022)

Time density curve of dynamic contrast-enhanced computed tomography correlates with histological characteristics of pancreatic cancer
por: Goto, Shintaro, et al.
Publicado: (2021)

Clinicopathological significance of vascular endothelial growth factor, thymidine phosphorylase and microvessel density in colorectal cancer
por: KIMURA, YUTAKA, et al.
Publicado: (2016)

Risk factor for permanent stoma and incontinence quality of life after sphincter‐preserving surgery for low rectal cancer without a diverting stoma
por: Miura, Takuya, et al.
Publicado: (2017)

Roles of the nervous system in pancreatic cancer
por: Wakiya, Taiichi, et al.
Publicado: (2021)

Radiomics-Based Pretherapeutic Prediction of Non-response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer
por: Zhou, Xuezhi, et al.
Publicado: (2019)

Long-Term Outcomes of Local Excision Following Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
por: D’Alimonte, Lucrezia, et al.
Publicado: (2020)

Impact of the histological phenotype of extrahepatic bile duct carcinoma
por: Okano, Kensuke, et al.
Publicado: (2018)

(18)F‑fluorodeoxyglucose positron emission tomography predicts recurrence and histological grade of extrahepatic bile duct cancer
por: Yachi, Takafumi, et al.
Publicado: (2023)

Treatment Interval between Neoadjuvant Chemoradiotherapy and Surgery in Rectal Cancer Patients: A Population-Based Study
por: Rombouts, A. J. M., et al.
Publicado: (2016)

Cost Effectiveness of Watch and Wait Versus Resection in Rectal Cancer Patients with Complete Clinical Response to Neoadjuvant Chemoradiation
por: Cui, Christina Liu, et al.
Publicado: (2021)

The Pretreatment Systemic Inflammatory Response is an Important Determinant of Poor Pathologic Response for Patients Undergoing Neoadjuvant Therapy for Rectal Cancer
por: Dreyer, Stephan B., et al.
Publicado: (2016)

Avoiding Unnecessary Major Rectal Cancer Surgery by Implementing Structural Restaging and a Watch-and-Wait Strategy After Neoadjuvant Radiochemotherapy
por: Huisman, J. F., et al.
Publicado: (2020)

Pathological Complete Response Following Different Neoadjuvant Treatment Strategies for Locally Advanced Rectal Cancer: A Systematic Review and Meta-analysis
por: Hoendervangers, S., et al.
Publicado: (2020)

Multiparametric MRI and Whole Slide Image-Based Pretreatment Prediction of Pathological Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer: A Multicenter Radiopathomic Study
por: Shao, Lizhi, et al.
Publicado: (2020)

A new histological therapeutic classification system to predict eradicated and residual lymph nodes in breast cancer after neoadjuvant chemotherapy
por: MOROHASHI, SATOKO, et al.
Publicado: (2016)

Long-Term Outcome of Patients with Complete Pathologic Response after Neoadjuvant Chemoradiation for cT3 Rectal Cancer: Implications for Local Excision Surgical Strategies
por: Belluco, Claudio, et al.
Publicado: (2011)

Organ/space infection is a common cause of high output stoma and outlet obstruction in diverting ileostomy
por: Hara, Yutaro, et al.
Publicado: (2020)

Short-term outcomes of robotic-assisted laparoscopic versus laparoscopic lateral lymph node dissection for advanced lower rectal cancer
por: Morohashi, Hajime, et al.
Publicado: (2020)

Essential updates 2018/2019: Current topics in the surgical treatment of pancreatic ductal adenocarcinoma
por: Ishido, Keinosuke, et al.
Publicado: (2020)

Long-Term Outcome of Rectal Cancer With Clinically (EUS/MRI) Metastatic Mesorectal Lymph Nodes Treated by Neoadjuvant Chemoradiation: Role of Organ Preservation Strategies in Relation to Pathologic Response
por: Belluco, Claudio, et al.
Publicado: (2016)

Primary rectal melanoma
por: Reid, A, et al.
Publicado: (2011)

Necrotizing pancreatitis complicated by retroperitoneal emphysema: two case reports
por: Chida, Kohei, et al.
Publicado: (2022)

Laparoscopic Sigmoidectomy for a Patient With Situs Inversus Totalis: Effect of Changing Operator Position
por: Yaegashi, Mizunori, et al.
Publicado: (2015)

Myofibroblasts of the muscle layer stimulate the malignant potential of colorectal cancer
por: Takatsuna, Masafumi, et al.
Publicado: (2016)

Robotic surgery contributes to the preservation of bowel and urinary function after total mesorectal excision: comparisons with transanal and conventional laparoscopic surgery
por: Miura, Takuya, et al.
Publicado: (2022)

Assessment of Clinical Complete Response After Chemoradiation for Rectal Cancer with Digital Rectal Examination, Endoscopy, and MRI: Selection for Organ-Saving Treatment
por: Maas, Monique, et al.
Publicado: (2015)

Treatment of Inguinal Lymph Node Metastases in Patients with Rectal Adenocarcinoma
por: Hagemans, J. A. W., et al.
Publicado: (2019)

Re-Irradiation in Patients with Recurrent Rectal Cancer is Safe and Feasible
por: Dijkstra, Esmée A., et al.
Publicado: (2021)

Survival in colon and rectal cancers in Finland and Sweden through 50 years
por: Hemminki, Kari, et al.
Publicado: (2021)

Navigation-Assisted Surgery for Locally Advanced Primary and Recurrent Rectal Cancer
por: Solbakken, Arne M., et al.
Publicado: (2023)

Optimal Treatment Strategy in Rectal Cancer Surgery: Should We Be Cowboys or Chickens?
por: Snijders, Heleen S., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_fu6c2qioh2len8q8amfc4uragb